Understood insurance coverage....So what?
What market needs to know is how many patients are being treated on a weekly/fortnightly or monthly basis? Also information on stock level.
I must say company needs to understand that what it important to them operationally is not what what is important to the market. Number of Vial sales is pertinent to create spark in SP and also provide some basic numbers to analysts to predict forecast. At this stage all is guesstimations and disclaimer to not rely of the information. Pretty much of waste of oxygen, isn't it?
Ann: Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives, page-29
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.035(1.88%) |
Mkt cap ! $2.331B | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.94 | $1.82 | $11.55M | 6.216M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 40245 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.84 | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |